Company Filing History:
Years Active: 1998
Title: Suman Kumar Mukherjee: Innovator in Neural Trauma Treatment
Introduction
Suman Kumar Mukherjee is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical science, particularly in the treatment of neural trauma. His innovative approach focuses on the use of NAD-related compounds to mitigate neural degeneration.
Latest Patents
Suman Kumar Mukherjee holds a patent for the "Use of NAD-related compounds in the treatment of neural trauma." This invention outlines methods for reducing neural degeneration in mammals following acute neural trauma through the administration of various NAD-related compounds. These compounds include quinolinic acid, nicotinamide, and nicotinamide adenine dinucleotide (NAD), among others. The patent emphasizes the potential of these compounds to improve recovery outcomes in affected individuals.
Career Highlights
Suman Kumar Mukherjee is associated with Neurocal International Inc., where he applies his expertise in developing innovative treatments for neural injuries. His work is characterized by a commitment to advancing medical science and improving patient care through research and development.
Collaborations
He collaborates with esteemed colleagues, including James David Adams and Lori Kathleen Klaidman, who contribute to the research and development efforts at Neurocal International Inc. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Suman Kumar Mukherjee's contributions to the field of neural trauma treatment exemplify the impact of innovative thinking in medicine. His patent on NAD-related compounds represents a significant advancement in therapeutic options for neural injuries.